On April 8, Bai Zhongquan, chairman of China National Pharmaceutical Group Co Ltd (Sinopharm), met with Hugh M Jones IV, CEO of Reed Exhibitions Limited (RX), during the China International Medical Equipment Fair (CMEF). They held discussions on strengthening synergistic collaboration, empowering development through digitalization and leveraging global exhibition resources.

Bai Zhongquan, chairman of Sinopharm, talks with Hugh M Jones IV, CEO of RX, on April 8, 2025. [Photo/sinopharm.com] 

Bai welcomed Jones and his delegation, highlighting the fruitful partnership between Sinopharm and RX since the establishment of their joint venture, Reed Sinopharm Exhibitions, in 2005. Over the past two decades, their mutual trust has laid a solid foundation for long-term cooperation. 

Bai shared Sinopharm’s recent progress in reform and development, noting the growing demand in China’s pharmaceutical and healthcare industry driven by rising public health awareness and an aging population. With innovation capabilities steadily improving, the industry outlook remains highly promising, Bai said. 

He emphasized that Sinopharm is accelerating its expansion across the entire pharmaceutical industrial chain to drive innovation in the healthcare sector. 

Recognizing RX as a global leader in exhibition and conference organization, with an extensive international network and expertise in digital services, Bai expressed his hope for deeper collaboration. He called for joint efforts to integrate resources and leverage strengths to deepen practical cooperation in areas such as digital empowerment, investment coordination, industrial innovation and support for the silver economy. 

Jones reaffirmed the strategic importance of Sinopharm as a global partner for RX. He said he was impressed by the group’s achievements across the pharmaceutical industrial chain, adding that attending CMEF and engaging with Sinopharm were key highlights of his trip to China. 

Jones praised the success of Reed Sinopharm Exhibitions, attributing its achievements to strong support from shareholders of both sides. He reiterated RX’s commitment to open collaboration and expressed keen interest in expanding investment in China and further advancing digital capabilities in partnership with Sinopharm.

Jones concluded by expressing hope that this meeting will serve as a springboard for future-focused investment and cooperation, particularly in digitalization, smart technologies and internationalization.

Executives from RX and Reed Sinopharm Exhibitions also attended the meeting.